Cargando…

Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale

OBJECTIVE: The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment tool for evaluating the cognitive deficit and daily functioning of patients with schizophrenia. METHODS: Sixty-eight patients with schizophrenia and 68 age- and sex-matched healthy individuals were recruited...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kuan-Wei, Lin, Pao-Yen, Lee, Yu, Huang, Yu-Chi, Hung, Chi-Fa, Lee, Sheng-Yu, Chen, Chih-Ken, Wang, Liang-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334803/
https://www.ncbi.nlm.nih.gov/pubmed/35903053
http://dx.doi.org/10.30773/pi.2021.0322
_version_ 1784759185999659008
author Huang, Kuan-Wei
Lin, Pao-Yen
Lee, Yu
Huang, Yu-Chi
Hung, Chi-Fa
Lee, Sheng-Yu
Chen, Chih-Ken
Wang, Liang-Jen
author_facet Huang, Kuan-Wei
Lin, Pao-Yen
Lee, Yu
Huang, Yu-Chi
Hung, Chi-Fa
Lee, Sheng-Yu
Chen, Chih-Ken
Wang, Liang-Jen
author_sort Huang, Kuan-Wei
collection PubMed
description OBJECTIVE: The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment tool for evaluating the cognitive deficit and daily functioning of patients with schizophrenia. METHODS: Sixty-eight patients with schizophrenia and 68 age- and sex-matched healthy individuals were recruited to validate the Chinese version of SCoRS in this study. All participants underwent cognitive assessment using the SCoRS, which was verified by the Brief Assessment of Cognition in Schizophrenia (BACS), and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B). Patients with schizophrenia were additionally assessed using the Positive and Negative Syndrome Scale (PANSS). RESULTS: SCoRS ratings reported by patients (SCoRS-S), those reported by the interviewer (SCoRS-I), and SCoRS global scores (SCoRS-G) showed significant correlation with all subscales of the BACS and the UPSA-B. On receiver operating characteristic curve analysis, SCoRS-S, SCoRS-I, and SCoRS-G significantly differentiated patients with schizophrenia from healthy controls. Moreover, SCoRS-S and SCoRS-I ratings showed positive correlation with the negative symptoms and general symptoms of PANSS. CONCLUSION: The Chinese version of SCoRS showed good discriminant, concurrent, and external validity, suggesting that it is a useful and convenient tool for assessment of cognitive function among Mandarin-speaking patients with schizophrenia in clinical practice.
format Online
Article
Text
id pubmed-9334803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-93348032022-07-29 Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale Huang, Kuan-Wei Lin, Pao-Yen Lee, Yu Huang, Yu-Chi Hung, Chi-Fa Lee, Sheng-Yu Chen, Chih-Ken Wang, Liang-Jen Psychiatry Investig Original Article OBJECTIVE: The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment tool for evaluating the cognitive deficit and daily functioning of patients with schizophrenia. METHODS: Sixty-eight patients with schizophrenia and 68 age- and sex-matched healthy individuals were recruited to validate the Chinese version of SCoRS in this study. All participants underwent cognitive assessment using the SCoRS, which was verified by the Brief Assessment of Cognition in Schizophrenia (BACS), and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B). Patients with schizophrenia were additionally assessed using the Positive and Negative Syndrome Scale (PANSS). RESULTS: SCoRS ratings reported by patients (SCoRS-S), those reported by the interviewer (SCoRS-I), and SCoRS global scores (SCoRS-G) showed significant correlation with all subscales of the BACS and the UPSA-B. On receiver operating characteristic curve analysis, SCoRS-S, SCoRS-I, and SCoRS-G significantly differentiated patients with schizophrenia from healthy controls. Moreover, SCoRS-S and SCoRS-I ratings showed positive correlation with the negative symptoms and general symptoms of PANSS. CONCLUSION: The Chinese version of SCoRS showed good discriminant, concurrent, and external validity, suggesting that it is a useful and convenient tool for assessment of cognitive function among Mandarin-speaking patients with schizophrenia in clinical practice. Korean Neuropsychiatric Association 2022-07 2022-07-21 /pmc/articles/PMC9334803/ /pubmed/35903053 http://dx.doi.org/10.30773/pi.2021.0322 Text en Copyright © 2022 Korean Neuropsychiatric Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Huang, Kuan-Wei
Lin, Pao-Yen
Lee, Yu
Huang, Yu-Chi
Hung, Chi-Fa
Lee, Sheng-Yu
Chen, Chih-Ken
Wang, Liang-Jen
Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title_full Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title_fullStr Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title_full_unstemmed Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title_short Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
title_sort validation of the chinese version of the schizophrenia cognition rating scale
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334803/
https://www.ncbi.nlm.nih.gov/pubmed/35903053
http://dx.doi.org/10.30773/pi.2021.0322
work_keys_str_mv AT huangkuanwei validationofthechineseversionoftheschizophreniacognitionratingscale
AT linpaoyen validationofthechineseversionoftheschizophreniacognitionratingscale
AT leeyu validationofthechineseversionoftheschizophreniacognitionratingscale
AT huangyuchi validationofthechineseversionoftheschizophreniacognitionratingscale
AT hungchifa validationofthechineseversionoftheschizophreniacognitionratingscale
AT leeshengyu validationofthechineseversionoftheschizophreniacognitionratingscale
AT chenchihken validationofthechineseversionoftheschizophreniacognitionratingscale
AT wangliangjen validationofthechineseversionoftheschizophreniacognitionratingscale